Kristbjörg Sveinsdóttir1, David Ley1, Holger Hövel2, Vineta Fellman1,3, Petra S Hüppi4, Lois E H Smith5, Ann Hellström6, Ingrid Hansen Pupp1. 1. Division of Pediatrics, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden. 2. Division of Pediatrics, Department of Clinical Sciences, Central Hospital Kristianstad, Lund, Sweden. 3. Children's Hospital, University of Helsinki, Helsinki, Finland. 4. Division of Development and Growth, Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland. 5. Department of Opthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. 6. Sahlgrenska Center for Pediatric Ophthalmology Research, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
Abstract
BACKGROUND: Retinopathy of prematurity (ROP) is a major complication of preterm birth and has been associated with later visual and nonvisual impairments. OBJECTIVES: To evaluate relationships between any stage of ROP, brain volumes, and developmental outcomes. METHODS: This study included 52 very preterm infants (gestational age [mean ± SD]: 26.4 ± 1.9 weeks). Total brain, gray matter, unmyelinated white matter (UWMV), and cerebellar volumes were estimated in 51 out of 52 infants by magnetic resonance imaging at term-equivalent age. Bayley Scales of Infant Development were used to assess developmental outcomes in 49 out of 52 infants at a mean corrected age of 24.6 months. RESULTS: Nineteen out of 52 infants developed any stage of ROP. Infants with ROP had a lower median (IQR) UWMV (173 [156-181] vs. 204 [186-216] mL, p < 0.001) and cerebellar volume (18.3 [16.5-20] vs. 22.3 [20.3-24.7] mL, p < 0.001) than infants without ROP. They also had a lower median (IQR) mental developmental index (72 [56-83] vs. 100 [88-104], p < 0.001) and a lower psychomotor developmental index (80 [60-85] vs. 92 [81-103], p = 0.002). Brain volumes and developmental outcomes did not differ among infants with different stages of ROP. CONCLUSION: Any stage of ROP in preterm infants was associated with a reduced brain volume and an impaired developmental outcome. These results suggest that common pathways may lead to impaired neural and neurovascular development in the brain and retina and that all stages of ROP may be considered in future studies on ROP and development.
BACKGROUND:Retinopathy of prematurity (ROP) is a major complication of preterm birth and has been associated with later visual and nonvisual impairments. OBJECTIVES: To evaluate relationships between any stage of ROP, brain volumes, and developmental outcomes. METHODS: This study included 52 very preterm infants (gestational age [mean ± SD]: 26.4 ± 1.9 weeks). Total brain, gray matter, unmyelinated white matter (UWMV), and cerebellar volumes were estimated in 51 out of 52 infants by magnetic resonance imaging at term-equivalent age. Bayley Scales of Infant Development were used to assess developmental outcomes in 49 out of 52 infants at a mean corrected age of 24.6 months. RESULTS: Nineteen out of 52 infants developed any stage of ROP. Infants with ROP had a lower median (IQR) UWMV (173 [156-181] vs. 204 [186-216] mL, p < 0.001) and cerebellar volume (18.3 [16.5-20] vs. 22.3 [20.3-24.7] mL, p < 0.001) than infants without ROP. They also had a lower median (IQR) mental developmental index (72 [56-83] vs. 100 [88-104], p < 0.001) and a lower psychomotor developmental index (80 [60-85] vs. 92 [81-103], p = 0.002). Brain volumes and developmental outcomes did not differ among infants with different stages of ROP. CONCLUSION: Any stage of ROP in preterm infants was associated with a reduced brain volume and an impaired developmental outcome. These results suggest that common pathways may lead to impaired neural and neurovascular development in the brain and retina and that all stages of ROP may be considered in future studies on ROP and development.
Authors: Adam L Rothman; Monica B Sevilla; Shwetha Mangalesh; Kathryn E Gustafson; Laura Edwards; C Michael Cotten; Joshua S Shimony; Carolyn E Pizoli; Mays A El-Dairi; Sharon F Freedman; Cynthia A Toth Journal: Am J Ophthalmol Date: 2015-09-18 Impact factor: 5.258
Authors: Nagamani Beligere; Vijayalaksmi Perumalswamy; Manish Tandon; Amit Mittal; Jayasheele Floora; B Vijayakumar; Marilyn T Miller Journal: Semin Fetal Neonatal Med Date: 2015-07-30 Impact factor: 3.926
Authors: William Hellström; Lisa M Hortensius; Chatarina Löfqvist; Gunnel Hellgren; Maria Luisa Tataranno; David Ley; Manon J N L Benders; Ann Hellström; Isabella M Björkman-Burtscher; Rolf A Heckemann; Karin Sävman Journal: Pediatr Res Date: 2022-06-09 Impact factor: 3.756
Authors: Jane E Brumbaugh; Edward F Bell; Shawn C Hirsch; Emma G Crenshaw; Sara B DeMauro; Ira S Adams-Chapman; Jean R Lowe; Girija Natarajan; Myra H Wyckoff; Betty R Vohr; Tarah T Colaizy; Heidi M Harmon; Kristi L Watterberg; Susan R Hintz Journal: Pediatr Res Date: 2021-10-22 Impact factor: 3.756
Authors: Eva Morsing; Mariya Malova; Anna Kahn; Jimmy Lätt; Isabella M Björkman-Burtscher; Karel Maršál; David Ley Journal: Front Physiol Date: 2018-11-16 Impact factor: 4.566
Authors: Pia Lundgren; Lena Jacobson; Anna-Lena Hård; Abbas Al-Hawasi; Eva Larsson; Lotta Gränse; Marie Saric; Birgitta Sunnqvist; Kristina Tornqvist; Agneta Wallin; Gerd E Holmstrom; Lois LE Smith; Eva Morsing; Ann Hellström Journal: BMJ Open Ophthalmol Date: 2021-04-21
Authors: Ulrika Sjöbom; William Hellström; Chatarina Löfqvist; Anders K Nilsson; Gerd Holmström; Ingrid Hansen Pupp; David Ley; Kaj Blennow; Henrik Zetterberg; Karin Sävman; Ann Hellström Journal: JAMA Netw Open Date: 2021-04-01